Home|Journals|Articles by Year

Directory for Medical Articles
 

Original Article

IJMDC. 2019; 3(5): 446-449


Prevalence, causes, treatment, and outcome of epistaxis

Zahi Mohammed Alqarni, Turke Ali Alajmi, Ussam Hussain Alhumaidi, Alhareth Alhussain, Yazeed Musaad Alotaibi, Hussam Saeed Alzahrani.


Abstract

Background:
Epistaxis is defined as acute hemorrhage from the nostril, nasal cavity, or nasopharynx. Nasal bleeding ranges from mild to severe life-threatening. Epistaxis may last from a few minutes to more than an hour. It rarely occurs in those less than 2 years of age but is commonly observed in children between 3-8 years of age. The current study was done to investigate the prevalence, causes, treatment, and outcome of epistaxis in Saudi population.
Methodology
This study was conducted on parents using an online survey; the survey investigated the clinical characteristics, demographics of children and parents. The Statistical package for the social sciences (SPSS program, V.20) was used to analyze the obtained data.
Results:
The prevalence of epistaxis among children was found to be 39.5%, and it was acute in 70.9%. The most common cause of epistaxis was the inflammatory diseases (50.5%) and the most common complication reported was recurrent epistaxis 12(15.2%). Observation alone was the most given management option 69.6%, recovery was obtained in 100% of patients.
Conclusion:
There was a moderate prevalence of epistaxis among children in the studied population. The study also concluded that observation and hospital stay could result in better outcomes and speedy recovery of epistaxis in children.

Key words: Epistaxis prevalence, children epistaxis, epistaxis management.






Full-text options


Share this Article



Online Article Submission
• ejmanager.com







eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.